Author Guidelines
Author Guidelines
Manuscript Preparation
The manuscript should be submitted as an MS Word file. The entire manuscript must be compiled into a single file. The corresponding author must provide his/her ORCID number (www.orcid.org) and/or Thomson-Reuters’ Researcher ID (www.researcherid.com).
Title Page
The title page should contain a clear, concise, and informative title of the article, followed by the names and affiliations of all authors. The affiliation should comprise the department, institution, city, and state (or nation) and should be typed as a footnote to the author’s name. The Corresponding Author must indicate his or her complete mailing address, office/cellular phone number, fax number, and email address at the lower left of the Title Page.
Article Structure
Abstract
The abstract should not exceed 400 words and must provide brief details about the study's objectives, materials and methods, results, and conclusions. The abstract should be unstructured; it must be written as a single paragraph without subheadings. The abstract must be followed by four to six keywords.
Introduction
This section should be brief and indicate the aim of the study along with essential background information. The introduction should clearly state the hypothesis or purpose statement, how and why it was developed, and why the author deems it important.
Materials and Methods
Please provide concise but complete information about the materials used, as well as the analytical, statistical, and experimental procedures employed. This part should be as clear as possible to enable other scientists to reproduce the research accurately. The use of subheadings to divide the text is highly encouraged. Primary headings should not be written in BOLD CAPITAL LETTERS. Secondary headings or subheadings should be in Bold and Italic sentence case. Third-level subheadings should be in italicized sentence case. In the case of animal/human experiments or clinical trials, authors must provide full details of ethical approval.
Results and Discussion
Data acquired from the research, along with the appropriate statistical analysis described in the methods section, should be included here. In this part, the same data or information given in a table must not be repeated in a figure or vice versa. Tables and Figures should be self-explanatory; it is unacceptable to extensively repeat numerals from tables into the text or to provide lengthy, unnecessary explanations. The discussion should relate the results to the current understanding of the scientific problems being investigated in the field.
Conclusion
This section should clearly explain the main conclusions of the work, highlighting its importance, impact, and scientific relevance.
References
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetical order). Identify references in the text, tables, and legends using Arabic numerals in superscript with square brackets after punctuation marks (e.g., $^{[1]}$). References cited only in tables or figure legends should be numbered following the sequence established by the first identification in the text of that particular table or figure.
Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. Journal titles should be abbreviated according to the style used in Index Medicus. Use the complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not yet accepted should be cited in the text as “unpublished observations” with written permission from the source. Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and the date of communication should be cited in parentheses within the text.
The commonly cited types of references are shown here. For other types of references (such as newspaper items), please refer to the ICMJE Guidelines (http://www.icmje.org).
Articles in Journals:
-
Standard journal article (up to six authors): Parija SC, Ravinder PT, Shariff M. Detection of hydatid antigen in the fluid samples from hydatid cysts by co-agglutination. Trans. R. Soc. Trop. Med. Hyg. 1996; 90:255–256.
-
Standard journal article (more than six authors): List the first six contributors followed by et al.
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N. et al. Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole Blood. J. Clin. Microbiol. 2008; 46: 2022-2027.
-
Volume with supplement: Otranto D, Capelli G, Genchi C. Changing distribution patterns of canine vector-borne diseases in Italy: leishmaniosis vs. dirofilariosis. Parasites & Vectors 2009; 1(Suppl 1):S2.
Books and Other Monographs:
-
Personal author(s): Parija SC. Textbook of Medical Parasitology. 3rd ed. All India Publishers and Distributors; 2008.
-
Editor(s), compiler(s) as author: Garcia LS. Filarial Nematodes. In: Garcia LS, editor. Diagnostic Medical Parasitology. ASM Press; 2007. p. 319-356.
-
Chapter in a book: Nesheim MC. Ascariasis and human nutrition. In: Crompton DWT, Nesheim MC, Pawlowski ZS, editors. Ascariasis and its prevention and control. Taylor and Francis; 1989. p. 87–100.
Electronic Sources:
-
Journal article on the Internet: Parija SC, Khairnar K. Detection of excretory Entamoeba histolytica DNA in the urine, and detection of E. histolytica DNA and lectin antigen in the liver abscess pus for the diagnosis of amoebic liver abscess. BMC Microbiology 2007; 7:41. doi:10.1186/1471-2180-7-41. http://www.biomedcentral.com/1471-2180/7/41
Tables & Figures
Tables and figures should not be embedded within the text; they must be included at the very end of the manuscript on separate pages. Tables should be created using a word processor and cited consecutively in the text. To ensure the highest print quality, figures must be submitted in TIF/JPG/JPEG format with a minimum resolution of 300 dpi or higher. Captions and legends must be placed below the figures and adjusted to a font size of 10.
Authorship and Acknowledgments
Authorship
All authors listed in a manuscript are equally responsible for the technical information communicated to the journal. Therefore, it is necessary that all authors read and approve the final version of the manuscript before submission. All named authors must have made an active contribution to the conception, design, analysis, interpretation of data, or the drafting/critical revision of the paper. Participation solely in the acquisition of funding or the collection of data does not justify authorship.
AMJS follows the definition of authorship established by the International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:
-
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
-
Drafting the work or revising it critically for important intellectual content; AND
-
Final approval of the version to be published; AND
-
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authors must meet all four conditions. In accordance with the requirements of this journal, all manuscripts must contain an "Authors’ Contributions" statement immediately before the Acknowledgments section.
Acknowledgments
All acknowledgments should be included at the very end of the paper before the references and may include supporting grants, presentations, and technical help. Contributors who do not qualify as authors should be mentioned under the Acknowledgments section.
Conflict of Interests
All authors must disclose any potential conflicts of interest or competing interests they may have regarding the publication of the manuscript, or with any institution or product mentioned that is important to the outcome of the study. Authors should also disclose conflicts of interest with products that compete with those mentioned in their manuscript. The Conflict of Interest statement should list each author separately by name.
Funding Sources
Authors must declare all sources of funding received for the research submitted to the journal. Authors should provide the names of the granting agencies and grant numbers, along with a short description of each funder’s role. Only funding directly related to the submitted work should be mentioned; authors are NOT required to provide a complete list of every single grant that supports them.
Originality and Plagiarism
Authors must ensure the absolute originality of their content while preparing the manuscript draft. If authors have used the work and/or words of others, this must be appropriately cited or quoted. All articles submitted to AMJS will be screened for plagiarism using iThenticate (online plagiarism detection software). If plagiarism is detected during the review or editorial process, the manuscript will be rejected immediately. Please read our plagiarism policy for details.
Reporting Standards
Authors of original research articles must present accurate data regarding the work performed. Authors are also expected to discuss the objective of their work and the objective significance of their results. An article should contain sufficient details and references to ensure the reproducibility of the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are strictly unacceptable.
Data Access and Retention
Authors may be asked to provide raw or supplementary data for a paper that is under editorial review. Authors should be prepared to provide public access to these data (if practicable) and to retain such data for a reasonable period after publication.
Peer Review
All manuscripts submitted to AMJS will be subjected to a double-blind peer-review process. Before starting a submission, authors should ensure that they are fully aware of our peer-review policy.
Ethical Approvals
Patient Rights
Patients have a right to privacy; therefore, all clinical studies must be conducted with informed consent. No identifying information (including names, detailed descriptions, photographs, or pedigrees) should be published unless the information is essential for scientific purposes and the patient (or parent/guardian) gives explicit written informed consent for publication. When informed consent has been obtained, it must be indicated clearly in the article. Investigations involving human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2000. All experiments must be approved by the institutional human experimentation committee or an equivalent body.
Animal Rights
Animal experiments must strictly follow the ethical standards for the care and use of laboratory animals. Articles involving animal experimentation must obtain prior approval from the appropriate Ethical Committee in accordance with the “Principles of Laboratory Animal Care” (NIH publication no. 85-23, revised 1985).
Clinical Trial Registry
We strongly advise authors to register their clinical trials with a recognized clinical trial registry that allows free online public access. Registration in the following trial registers is acceptable:
Abbreviations
Standard abbreviations should be used consistently throughout the manuscript. All nonstandard abbreviations should be kept to a minimum and must be explicitly defined in the text upon their first use.